Panelists discuss how Bruton tyrosine kinase (BTK) inhibitors have transformed the treatment paradigm for patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL ...
Patient-Centered Selection of BTK Inhibitors: Balancing Clinical Factors and Patient Preferences EP: 16 . Implementation of Shared Decision-Making in BTK Inhibitor Treatment ...